This trial will test a new strategy, called FAMES, to help families support their loved ones with psychosis in coordination with specialized care programs.
3 Primary · 5 Secondary · Reporting Duration: Baseline through study completion, an average of 1 year; repeated measure to assess change through study completion
55 Total Participants · 2 Treatment Groups
Primary Treatment: FAMES · No Placebo Group · N/A
Age 18+ · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: